Loading...
Loading...
SQL| Name | Value |
|---|---|
| Revenues | 442.6M |
| Cost of Revenue | 395.4M |
| Gross Profit | 47.2M |
| Operating Expense | 63.1M |
| Operating I/L | -17.3M |
| Other Income/Expense | -108.4M |
| Interest Income | -0.1M |
| Pretax | -125.7M |
| Income Tax Expense | -5.3M |
| Net Income/Loss | -131.1M |
SeqLL Inc. is a global life sciences instrumentation and research services company specializing in genetic analysis technologies. The company's true single molecule sequencing (tSMS) platform provides a unique solution for DNA and RNA sequencing. SeqLL generates revenue by designing, developing, and manufacturing these cutting-edge genetic analysis technologies. The company has established collaboration agreements with various research institutions and diagnostic companies, serving a wide range of clients including academic and government institutions, hospitals, pharmaceutical and biotechnology companies, and non-profit research organizations.
